DE60333207D1 - Pantethin enthaltendes teilchenförmiges produkt - Google Patents

Pantethin enthaltendes teilchenförmiges produkt

Info

Publication number: DE60333207D1
Authority: DE; Germany
Prior art keywords: pantethin; containing particle; pantethine; particle product; microcrystalline cellulose
Prior art date: 2002-09-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60333207T

Other languages

English (en)

Inventor

M Kidokoro

Y Tsutsumi

Mitsumasa Nada

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Daiichi Sankyo Co Ltd

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-30

Filing date

2003-09-29

Publication date

2010-08-12

2003-09-29 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2010-08-12 Application granted granted Critical

2010-08-12 Publication of DE60333207D1 publication Critical patent/DE60333207D1/de

2023-09-30 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Inorganic Chemistry (AREA)
Obesity (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cosmetics (AREA)
Detergent Compositions (AREA)

DE60333207T 2002-09-30 2003-09-29 Pantethin enthaltendes teilchenförmiges produkt Expired - Lifetime DE60333207D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002286286		2002-09-30
PCT/JP2003/012408 WO2004028523A1 (ja)	2002-09-30	2003-09-29	パンテチン含有粒状物

Publications (1)

Publication Number	Publication Date
DE60333207D1 true DE60333207D1 (de)	2010-08-12

Family

ID=32040603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60333207T Expired - Lifetime DE60333207D1 (de)	2002-09-30	2003-09-29	Pantethin enthaltendes teilchenförmiges produkt

Country Status (10)

Country	Link
US (1)	US7709028B2 (de)
EP (1)	EP1547584B1 (de)
JP (1)	JP4496078B2 (de)
CN (1)	CN100362987C (de)
AT (1)	ATE472321T1 (de)
AU (1)	AU2003266676A1 (de)
CA (1)	CA2501021C (de)
DE (1)	DE60333207D1 (de)
ES (1)	ES2345713T3 (de)
WO (1)	WO2004028523A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2476408A4 (de)	2009-09-11	2013-03-06	Daiichi Fine Chem Co Ltd	Externes präparat mit pantethin-phosphat-ester
FR2958166B1 (fr) *	2010-04-06	2012-07-13	Assist Publ Hopitaux De Paris	Compositions pharmaceutiques fortement dosees en biotine
FR2993780B1 (fr)	2012-07-26	2015-02-13	Assist Publ Hopitaux De Paris	Methode de traitement de la sclerose en plaque
US9789092B2 (en)	2013-04-29	2017-10-17	Assistance Publique—Hopitaux de Paris	Biotin for use in treating X-linked adrenoleukodystrophy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS532931B2 (de) *	1973-12-05	1978-02-01
JPS54122737A (en) *	1978-03-13	1979-09-22	Dai Ichi Seiyaku Co Ltd	Remedy for pericementosis
JPS54126737A (en) *	1978-03-17	1979-10-02	Dai Ichi Seiyaku Co Ltd	Antithrombotic agent
JPS5538344A (en)	1978-09-12	1980-03-17	Dai Ichi Seiyaku Co Ltd	Manufacturing of pantethine powder
JPS5936606A (ja) *	1982-08-26	1984-02-28	Sogo Yatsukou Kk	美白化粧料
JPS5949840A (ja) *	1982-09-14	1984-03-22	Taiyo Yakuhin Kogyo Kk	顆粒、細粒の固着防止方法
JPS6479119A (en) *	1987-09-22	1989-03-24	Daiichi Seiyaku Co	Drug of blended two components
US4910023A (en) *	1988-06-09	1990-03-20	Warner-Lambert Company	Drug in combination with flavor masking agent and method for making same
JPH07233070A (ja) *	1994-02-23	1995-09-05	Taisho Pharmaceut Co Ltd	疲労改善剤
JPH09143088A (ja) *	1995-09-21	1997-06-03	Taisho Pharmaceut Co Ltd	滋養強壮保健剤
WO1998002185A1 (en) *	1996-07-12	1998-01-22	Daiichi Pharmaceutical Co., Ltd.	Quickly disintegrable compression-molded materials and process for producing the same
JP2001187734A (ja) *	1999-12-28	2001-07-10	Taisho Pharmaceut Co Ltd	２型ｔヘルパー細胞分化抑制剤

2003
- 2003-09-29 WO PCT/JP2003/012408 patent/WO2004028523A1/ja not_active Ceased
- 2003-09-29 JP JP2004539566A patent/JP4496078B2/ja not_active Expired - Lifetime
- 2003-09-29 US US10/529,207 patent/US7709028B2/en not_active Expired - Lifetime
- 2003-09-29 AT AT03798538T patent/ATE472321T1/de not_active IP Right Cessation
- 2003-09-29 AU AU2003266676A patent/AU2003266676A1/en not_active Abandoned
- 2003-09-29 CA CA2501021A patent/CA2501021C/en not_active Expired - Lifetime
- 2003-09-29 ES ES03798538T patent/ES2345713T3/es not_active Expired - Lifetime
- 2003-09-29 CN CNB038232332A patent/CN100362987C/zh not_active Expired - Lifetime
- 2003-09-29 EP EP03798538A patent/EP1547584B1/de not_active Expired - Lifetime
- 2003-09-29 DE DE60333207T patent/DE60333207D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2501021C (en)	2011-02-22
US7709028B2 (en)	2010-05-04
ES2345713T3 (es)	2010-09-30
CN100362987C (zh)	2008-01-23
CA2501021A1 (en)	2004-04-08
ATE472321T1 (de)	2010-07-15
EP1547584A1 (de)	2005-06-29
WO2004028523A1 (ja)	2004-04-08
EP1547584B1 (de)	2010-06-30
CN1697653A (zh)	2005-11-16
EP1547584A4 (de)	2005-12-14
JP4496078B2 (ja)	2010-07-07
US20060068016A1 (en)	2006-03-30
JPWO2004028523A1 (ja)	2006-01-19
AU2003266676A1 (en)	2004-04-19

Publication	Publication Date	Title
CY1114668T1 (el)	2016-10-05	Κοκκια περιεχοντα λανσοπραzολη σε μεγαλη ποσοτητα
EA200702638A1 (ru)	2008-04-28	Стабильная композиция (рецептура) с наночастицами ацетаминофена
ATE529499T1 (de)	2011-11-15	Granulat eines sensitiven wasch- oder reinigungsmittelinhaltsstoffs
DK1353548T3 (da)	2006-02-20	Formalet kornströelse til dyr
DE60217844D1 (de)	2007-03-15	Trocknungszusammensetzung
EA199900318A1 (ru)	1999-12-29	Способ производства гранул цеолита х с низким содержанием двуокиси кремния с низким содержанием инертного связующего
WO2005013937A3 (en)	2005-06-16	Novel compositions of sildenafil free base
ATE550012T1 (de)	2012-04-15	Zusammensetzung mit dichten kapseln mit einem sonnenschutzmittel
DE60026970D1 (de)	2006-05-18	Zusammensetzungen mit niedriger dichte und partikeln der diese enthalten
ATE214089T1 (de)	2002-03-15	Zusammensetzungen enthaltend natriumpercarbonat
DK1658047T3 (da)	2008-06-16	Spraytörret amorft pulver med en lav resterende fugtighed og udmærket lagerstabilitet
EP1097722A4 (de)	2002-03-20	Trägerhilfstoff
NO20055943L (no)	2006-01-25	Bicalutamidformer, sammensetninger og fremgangsmater derav
DE60333207D1 (de)	2010-08-12	Pantethin enthaltendes teilchenförmiges produkt
ATE232728T1 (de)	2003-03-15	Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
MX2022000816A (es)	2022-05-13	Composiciones de pretomanida.
NO308607B1 (no)	2000-10-02	Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
DE60236025D1 (de)	2010-05-27	Pharmazeutische zusammensetzung enthaltend l-arginin
WO2008090732A1 (ja)	2008-07-31	医薬組成物
ATE357217T1 (de)	2007-04-15	Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
BR9813602A (pt)	2002-01-22	Composições farmacêuticas contendo medicamentos bicìclicos micronizados
EA200801572A1 (ru)	2008-10-30	Фармацевтическая композиция, содержащая аморфный аторвастатин
ITMI20041251A1 (it)	2004-09-22	Gel di perfluoroelastomeri
ATE503464T1 (de)	2011-04-15	Fliessfähige, pulverförmige alpha-liponsäure(- derivate) enthaltende zusammensetzung
ES2058944T3 (es)	1994-11-01	Procedimiento para la produccion de aglomerados de peroxoborato.